JW Pharmaceutical Corp
KRX:001060
JW Pharmaceutical Corp
KRX:001060
Price:
30 200
KRW
-2.89%
Market Closed
Market Cap:
₩720B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
JW Pharmaceutical Corp
KRX:001060
|
KR |
|
AIX Inc
NASDAQ:AIFU
|
CN |
|
P
|
Providence Resources PLC
LSE:PVR
|
IE |
|
Fluence Energy Inc
NASDAQ:FLNC
|
US |
|
A
|
Anhui Genuine New Materials Co Ltd
SSE:603429
|
CN |
|
Physiomics PLC
LSE:PYC
|
UK |
|
N
|
Nippon Dry-Chemical Co Ltd
TSE:1909
|
JP |
|
S
|
Shen Yao Holdings Ltd
SGX:A78
|
SG |
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
KR |
|
N
|
Notion VTec Bhd
KLSE:NOTION
|
MY |
Multiples-Based Value
The
Multiples-Based Value for
JW Pharmaceutical Corp (001060)
under the Base Case is
hidden
KRW.
Compared with the current market price of 30 200 KRW, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
JW Pharmaceutical Corp Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
JW Pharmaceutical Corp Competitors
JW Pharmaceutical Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
|
JW Pharmaceutical Corp
KRX:001060
|
691.2B KRW | 0.9 | 12 | 5.9 | 7.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
